Clinical trial
To Determine How Effective Duloxetine is in Treating Women 65 Years and Older…
NCT00244296 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00244296 |
|---|---|
| Title | To Determine How Effective Duloxetine is in Treating Women 65 Years and Older With Symptoms of Stress Urinary Incontinence, or With a Combination of Stress Urinary Incontinence and Urge Urinary Incontinence Symptoms |
| Official title | A Double-Blind, Stratified, Randomised, Parallel, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy and Safety of Duloxetine (20 mg Bid for 2 Weeks Escalating to 40 mg Bid) for up to 12 Weeks, Compared to Placebo, in Community-Dwelling Elderly Women > or = 65 Years of Age With Symptoms… |
| Lead sponsor | Eli Lilly and Company, Industry |
| Collaborators | Boehringer Ingelheim Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Urinary Incontinence, Stress |
| Intervention type | Drug |
| Interventions | Duloxetine hydrochloride, placebo |
| Enrollment | 276 |
| Start date | Oct 1, 2005 |
| Completion | Jan 1, 2007 |
| First posted | Oct 26, 2005 |
| Last update posted | Jan 26, 2007 |
| Countries | France, Germany, Netherlands, South Africa, Spain, Sweden, Switzerland |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: